Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Gilead pays partner Hookipa $10M for HBV, HIV vaccines
Gilead is paying $10 million for sole ownership of arenaviral immunotherapies for hepatitis B and HIV.
James Waldron
May 22, 2025 10:10am
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
May 21, 2025 8:30am
Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific
May 20, 2025 4:47am
Lilly strengthens RNA pipeline with $1.3B hearing loss pact
May 16, 2025 7:34am
AbbVie tosses ADARx $335M for siRNA options deal
May 14, 2025 9:00am
GSK pays $1.2B upfront for Boston's lead liver disease drug
May 14, 2025 2:53am
